Table 1.
Disease | Commercial Name of Vaccine | Vaccine Type | Manufacturer | Countries available |
---|---|---|---|---|
Yellow Fever | 17DD | Live attenuated | Bio-Manguinhos, Brazil | Brazil |
17D–204 (Stamaril® in Senegal) | Sanofi Pasteur France | France | ||
Chumakov Institute of Poliomyelitis and Viral Encephalitides (IPVE), Moscow | Russia | |||
17D–204 YF-VAX® |
Sanofi Pasteur, USA | USA | ||
17D–204 Yellow Fever Vaccine (live) |
Beijing Tiantan Biological Products, China | China | ||
Japanese encephalitis | IXIARO® (SA14–14–2) |
Inactivated | Valneva SE (France), Biological E (India) | Europe, USA, Canada, Hong Kong, Singapore, and Israel, Norway, Liechtenstein, and Iceland. |
JESPECT® | Inactivated | Australia and New Zealand | ||
CD. JEVAXTM (SA14–14–2) | Live attenuated | Chengdu Institute of Biological Products (China) | China, Cambodia, North Korea, India, Laos, Myanmar, Nepal, South Korea, Sri Lanka, and Thailand. | |
IMOJEV® | Live attenuated Chimeric vaccine (prM/E genes replaced YFV–17D genes) |
Sanofi Pasteur (France) | Australia | |
THAIJEV® | Thailand | |||
Tick-borne encephalitis | FSME-IMMUNE | Inactivated | Pfizer | Vienna and Austria |
Encepur | GlaxoSmithKline | Germany | ||
TBE-MOSCOW | Chumakov Institute of Poliomyelitis and Viral Encephalitides (IPVE),Moscow | Russia | ||
EnceVir | Microgen, Tomsk, Russia | Russia | ||
CIBP | Changchun Institute of Biological Products, China | China |